Cullinan Oncology shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Cullinan Oncology (CGEM) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Cullinan Oncology
Tip: Access up to 7 years of quarterly data
All positions including Cullinan Oncology held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Cullinan Oncology by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $189k | 32k | 5.93 |
| 2025-03-31 | $330k | 44k | 7.57 |
| 2024-12-31 | $2.4M | 198k | 12.18 |
| 2024-09-30 | $487k | 29k | 16.74 |
| 2024-06-30 | $406k | 23k | 17.44 |
| 2024-03-31 | $332k | 20k | 17.04 |
| 2023-12-31 | $257k | 25k | 10.19 |
| 2023-09-30 | $220k | 24k | 9.05 |
| 2023-06-30 | $223k | 21k | 10.76 |
| 2023-03-31 | $30k | 2.2k | 13.51 |
| 2022-12-31 | $204k | 19k | 10.54 |
| 2022-06-30 | $235k | 18k | 13.04 |
| 2022-03-31 | $255k | 24k | 10.54 |
| 2021-12-31 | $309k | 20k | 15.40 |
| 2021-03-31 | $1.6M | 38k | 41.65 |